A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Condition:   B-cell Non Hodgkin Lymphoma Interventions:   Drug: Odronextamab;   Drug: Loncastuximab tesirine;   Drug: Rituximab;   Drug: Ifosfamide;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Etoposide Phosphate;   Drug: Dexamethasone;   Biological: CAR T-cells (TBC) Sponsors:   University of Birmingham;   Cancer Research UK;   Fight Kids Cancer;   Regeneron Pharmaceuticals;   ADC Therapeutics SA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials